Brief: On Jan. 10, NextCure And Eli Lilly Notified Lilly's Termination Of Research & Development Collaboration Agreement
Jan 13 (Reuters) - NextCure Inc NXTC.O :
* NEXTCURE - ON JAN 10, 2020, ELI LILLY AND CO NOTIFIED CO
OF
LILLY'S TERMINATION OF RESEARCH & DEVELOPMENT COLLABORATION
AGREEMENT, DATED NOV 2, 2018
Source: (http://bit.ly/37ZkDUo)
Further company coverage: NXTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NextCure
See all newsBrief: Xcellon Biologics Co Acquires Gmp Manufacturing Facility From Nextcure
NextCure Inc reports results for the quarter ended June 30 - Earnings Summary
NextCure Q2 net loss narrows on lower expenses
Brief: NextCure Q2 Net Income USD -14.892 Million
NextCure Inc expected to post a loss of $1.93 a share - Earnings Preview